• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

AuraSense Therapeutics

edit

AuraSense Therapeutics, LLC is a privately held biopharmaceutical company founded by Professors Chad A. Mirkin and C. Shad Thaxton at Northwestern University. The Company is dedicated to developing and commercializing spherical nucleic acid (SNA™) conjugates. Its proprietary SNA constructs possess unparalleled biocompatibility and versatility as therapeutics, and they hold great promise for combating the world’s most threatening diseases. The Company’s SNA technology overcomes the most difficult obstacles to gene regulation: genetic targeting with safe and effective in vivo performance.

Recent Milestones

edit

• 
  AuraSense Therapeutics received $5.4M in Series B funding. (12/21/11)
  Posted 1/30/12 at 6:15pm via onbiovc.com
• 
  AuraSense Therapeutics added Chad A. Mirkin as Founder.
  Posted 1/30/12 at 6:15pm
• 
  AuraSense Therapeutics added C. Shad Thaxton as Founder.
  Posted 1/30/12 at 6:15pm

Videos

Screenshots

edit

Sources

1. AuraSense Therapeutics, LLC: Series B $5.4M (onbiovc.com) [edit]